Therapy & Business Area Training for Pharmaceutical, Medical Technology & Biotechnology Professionals
Industry professionals progress rapidly with face-to-face learning from leading physicians and experts.
Healthcare Education Services continues to be the leading provider of education programmes to the pharmaceutical, medical device, medical diagnostics and biotechnology industries. Industry professionals gain from Healthcare’s face-to-face, small group learning and high calibre education programmes in subject areas including Pricing & Reimbursement, Oncology, Cardiology, Asthma & COPD, Alzheimer’s Disease, Diabetes, Psychiatric Disorders and Health Economics. Delegates benefit from traditional lectures, discussion and Q&A with Healthcare’s eminent speakers.
“Rapid and progressive learning enables delegates to extend their knowledge fast encouraging the ability to discuss a subject credibly and confidently," explained Valerie Smith, Medical Education Director at Healthcare.
Healthcare’s course information and booking can be found at healthcare-ed.com. Courses in 2014 for open enrolment are held in central London apart from Oncology Clinical Experience, which is an exclusive and unique, hospital-based opportunity for training in a hospital setting, combining traditional lectures with practical example and takes place in Leeds, UK.
Pricing & Reimbursement: An Introduction, 4–5 March
Asthma & COPD: An Overview, 12–13 March
Biomarkers: Their Application in Clinical Trials, 19–20 March
Alzheimer’s Disease: An Overview, 26–27 March
Epilepsy: An Overview, 2–3 April
Diabetes: An Overview, 2–3 April
Psychiatric Disorders: An Overview, 13–14 May
Introduction to Oncology and Its Treatment, 21–22 May
Cardiovascular Medicine: An Overview, 8–9 Oct
Immunotherapies: An Overview, 6 Nov
Oncology Clinical Experience Programme, 11–14 Nov
Oncology: Phase III Trials, 14–15 Nov
Haematological Malignancies, 18–19 Nov
Breast Cancer: Treatment & Management, 27 Nov
Health Economics for Pharmaceutical Personnel, 2–3 Dec
Medical education programmes developed by Healthcare Education Services are approved by the Faculty of Pharmaceutical Medicine for Continuing Professional Development (CPD) accreditation. They are ideal for personnel working in clinical research, medical information and regulatory affairs, biometrics, strategic marketing and other key industry roles.
Healthcare offers training for open enrolment and private commission. Open enrolment training is held in central locations with easy travel access. Privately commissioned programmes are held at a venue of client choice with the programme tailored to meet client objectives. Courses are held across the UK, Europe, US and worldwide.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.